The effectiveness of molnupiravir against Omicron has yet to be evaluated in clinical trials, said Merck, known as MSD outside the United States and Canada.
from Top World News- News18.com https://ift.tt/3g8iA6K
via Click here
from Top World News- News18.com https://ift.tt/3g8iA6K
via Click here
Comments
Post a Comment